The aim of this paper was to review recent literature on the HIV-1 genotypic and phenotypic resistance determinants of therapeutic response to newly approved protease inhibitors and the viral resistance pathways to these and to investigational protease inhibitors.

DE LUCA, A. (2007). Resistance to newly approved and investigational protease inhibitors. CURRENT OPINION IN HIV AND AIDS, 2(2), 130-136 [10.1097/COH.0b013e3280287a38].

Resistance to newly approved and investigational protease inhibitors

DE LUCA, ANDREA
2007-01-01

Abstract

The aim of this paper was to review recent literature on the HIV-1 genotypic and phenotypic resistance determinants of therapeutic response to newly approved protease inhibitors and the viral resistance pathways to these and to investigational protease inhibitors.
2007
DE LUCA, A. (2007). Resistance to newly approved and investigational protease inhibitors. CURRENT OPINION IN HIV AND AIDS, 2(2), 130-136 [10.1097/COH.0b013e3280287a38].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1011581
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo